Glenmark Generics recalls Montelukast Sodium tablets from US market

19 Mar 2013 Evaluate

Glenmark Generics is recalling multiple lots of Montelukast Sodium tablets (10 mg), from the US market due to odor complaints from US Food and Drug Administration. The tablet is used in treatment of chronic asthma and prophylaxis. The entity will be withdrawing as many as 591,972 bottles of Montelukast Sodium tablets of both 30 and 90-count from the market.

Glenmark Generics is a subsidiary of Glenmark Pharmaceuticals (Glenmark) and aims to be a global integrated Generic and API leader. GGL has an established presence in North America, a developing EU presence and Argentina and maintains marketing front-ends in these countries.

Glenmark Pharma Share Price

1592.90 -33.65 (-2.07%)
09-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.10
Dr. Reddys Lab 1371.60
Cipla 1488.15
Lupin 2251.80
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.